Read Full Story More than painted bike lanes are needed to keep bicyclists safe on Boston’s busy streets, a Harvard T.H. Chan School of Public Health researcher said Sept. 14 at a Boston City Council public hearing on how to make roads safer for cyclists in the city.Anne Lusk, research scientist in the Department of Nutrition, was among the bicycle safety advocates who urged members of a council committee to do more to protect bike riders. She advocated for more cycle tracks, which are physical barriers next to sidewalks that separate cars and bikes.“Bike lanes are safer for the pedestrians, bike lanes are safer for the car drivers — bike lanes are less safe for the bicyclists,” Lusk said in a September 15, 2015 WBUR article. “And Boston will proudly talk about the miles and miles and miles of bike lanes that are going to be put in. You’re putting in bicycle facilities that are less safe for the bicyclists.”About 12 bicyclists have been killed in Boston in the last five years, including two recent cases in which the cyclists were reportedly inside painted bike lanes, according to WBUR.
Growing pipeline of TB drugs The Department of Health has welcomed the development, noting that it could benefit not only South Africa but the whole world in the fight against TB. “The potential to offer a single regimen to treat both DS and MDR-TB represents a monumental advance in the treatment of patients worldwide and a tremendous step toward simplifying the delivery of TB treatment globally,” Spigelman said. Novel three-drug combination A novel three-drug combination with the potential of simplifying and shortening TB treatment from two years to less than six months is currently been tested on patients in South Africa. “We welcome the fresh development, which will assist in bringing down the period of taking the treatment, which is one of the main reasons for patients defaulting,” said department spokesperson Fidel Hadebe. 9 November 2010 If successful, the experimental regimen will offer a shorter, simpler, safer and more affordable treatment option for MDR-TB, an emerging global health threat. This is particularly significant for MDR-TB patients, who currentlty have to take numerous different drugs, including injections, daily for up to two years. The announcement of the first clinical trial of the TB drug combination was made in Pretoria on Monday by the Global Alliance for TB Drug Development, a non-profit organisation dedicated to finding faster-acting and affordable drug regimens to fight tuberculosis. ‘Monumental advance’ in treatment The three-drug combination promises to be capable of treating both drug-sensitive (DS-TB) and multidrug-resistant TB (MDR-TB). “It is extremely encouraging to see a growing pipeline of TB drug candidates that may revolutionise TB care, and committed sponsors moving with speed and efficiency towards new regimens,” said Raviglione. The Phase II trial, called NC001 or New Combination 1, tests the new TB drug candidates PA-824 and moxifloxacin in combination with pyrazinamide, an existing antibiotic commonly used in TB treatment today. He said that with increased investments in TB, there were nine promising TB compounds from six antibiotic classes in the pipeline, making combination testing of new TB drugs possible. TB Alliance CEO Mel Spigelman said what was needed was an entirely new regimen of TB drugs rather than one single drug to eradicate the pandemic. The trial, which will take place at the Lung Institute at the University of Cape Town and the TASK Research Centre in Belville, involves 68 participants, each receiving two weeks of treatment and three months of follow-up to evaluate the drugs’ effectiveness, safety and tolerability. World Health Organisation’s Stop TB department MD Mario Raviglione said there was a desperate need for new and better TB treatments to address the pandemic, which kills nearly two million people each year. He noted that treating active TB requires a combination of drugs to prevent the development of drug resistance, adding that researchers traditionally tested one new drug at a time in a series of lengthy and expensive clinical trials, meaning it would take decades to develop a completely novel drug combination. SAinfo reporterWould you like to use this article in your publication or on your website? See: Using SAinfo material
Get the Free eBook! Learn how to sell without a sales manager. Download my free eBook! You need to make sales. You need help now. We’ve got you covered. This eBook will help you Seize Your Sales Destiny, with or without a manager. Download Now The elevator door opened and I started to walk out when I noticed I had only gone from the 7th floor to the 6th floor. I had pushed the button to go to the lobby. This wasn’t one of those times when you are on an elevator and not paying attention. In this case, the building was old, as was the elevator. Enough time had passed that I should have been in the lobby, but the elevator didn’t move for some time after I pressed the button.Time and Ground CoveredThere is a certain amount of ground you can cover in a period. Call that ground a goal, a milestone, a quota, or a chapter. The time passes whether or not you cover the ground.Some people recognize that time relentlessly ticks away and feel the need to increase their progress toward their goals. Others don’t feel the same urgency, being more passive and complacent about time—even though they have no more time than those who act with purpose. Time is not a variable; it’s universal. It doesn’t treat anyone differently and offers no one a preference. It just relentlessly counts off its beats.The ground covered is a variable, and it is inside your control. There are two areas you need to consider: values-based decisions and effort. If you want to cover more ground faster, then you need to prioritize those things that move you forward further and more quickly. The decision as to what you do with your time is yours alone. You also have to do the work, putting the effort and energy into the work.Otherwise, you can look up and think you should have gone somewhere only to find yourself standing very close to where you started.
The shocked family of Swami Nigamanand Saraswati has demanded a high-level probe, alleging that he was poisoned under a conspiracy by forces working “against his noble mission to make the Ganga pollution free”.The swamiss family is based in the Ladari village under Keoti police station in Darbhanga district of Bihar. It expressed dismay that while the Uttarakhand government had arranged for the best medical facilities for yoga guru Baba Ramdev, who was also admitted to the same hospital during his recent fast against corruption, it completely ignored Nigamanand.Nigamanand’s grandfather Surya Narayan Jha claimed that Nigamanand was poisoned to death during treatment and accused the Uttarakhand government of insensitivity. He also sought a probe into the role of Nigamanand’s guru Swami Shivanand Maharaj of the Matri Sadan Ashram, Haridwar, accusing him of forcing him to go on a fast.Jha said Swami Shivanand had never let any of his family members meet Nigamanand at his ashram in the past.Nigamanand’s aunt Rekha Jha said the 34-year-old swami had also gone on fast on two other occasions in the past “at the behest of his guru”. She said thatthe Uttarakhand chief minister was aware of his condition and had once visited Nigamanand asking him to give up his fast but the latter refused. “After that, nobody visited him,” she said. “He has been murdered under a conspiracy,” she said.The young ascetic’s death had cast a pall of gloom on his village. His parents had gone to Haridwar after receiving the news of Nigamanand’s demise. Most of the villagers wanted the body of Nigamanand to be brought back to his native place for cremation. “We want the state government’s help in bringing his body to our village,” a villager said. “We want to pay homage to him for his supreme sacrifice to make the Ganga pollution free.”advertisementFor more news on India, click here.For more news on Business, click here.For more news on Movies, click here.For more news on Sports, click here.